País: Estados Unidos
Idioma: inglés
Fuente: NLM (National Library of Medicine)
AMOXICILLIN (UNII: 804826J2HU) (AMOXICILLIN ANHYDROUS - UNII:9EM05410Q9)
Direct RX
AMOXICILLIN
AMOXICILLIN ANHYDROUS 875 mg
ORAL
PRESCRIPTION DRUG
- To reduce the development of drug-resistant bacteria and maintain the effectiveness of amoxicillin tablets, USP and other antibacterial drugs, amoxicillin tablets, USP should be used only to treat infections that are proven or strongly suspected to be caused by bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. Amoxicillin tablets, USP are indicated in the treatment of infections due to susceptible (ONLY β-lactamase–negative) isolates of the designated bacteria in the conditions listed below: 1.1 Infections of the Ear, Nose, and Throat Due to Streptococcus species (α- and β-hemolytic isolates only), Streptococcus pneumoniae, Staphylococcus spp., or Haemophilus influenzae. 1.2 Infections of the Genitourinary Tract Due to Escherichia coli, Proteus mirabilis, or Enterococcus fae
Amoxicillin Tablets, USP contains 500 mg or 875 mg amoxicillin as the trihydrate. 500 mg Tablet Pink colored, capsule shaped, film coated tablets debossed with “A” on one side and “66” on the other side. Bottles of 20 NDC 65862-014-20 Bottles of 100 NDC 65862-014-01 Bottles of 500 NDC 65862-014-05 875 mg Tablet Pink colored, capsule shaped, film coated tablets debossed with “A” on one side and with a score line in between “6” and “7” on the other side. Bottles of 20 NDC 65862-015-20 Bottles of 100 NDC 65862-015-01 Bottles of 500 NDC 65862-015-05
Abbreviated New Drug Application
AMOXICILLIN- AMOXICILLIN TABLET, FILM COATED TABLET DIRECT RX ---------- AMOXICILLIN - AMOXICILLIN TABLET, FILM COATED 1 INDICATIONS AND USAGE To reduce the development of drug-resistant bacteria and maintain the effectiveness of amoxicillin tablets, USP and other antibacterial drugs, amoxicillin tablets, USP should be used only to treat infections that are proven or strongly suspected to be caused by bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. Amoxicillin tablets, USP are indicated in the treatment of infections due to susceptible (ONLY β- lactamase–negative) isolates of the designated bacteria in the conditions listed below: 1.1 Infections of the Ear, Nose, and Throat Due to Streptococcus species (α- and β-hemolytic isolates only), Streptococcus pneumoniae, Staphylococcus spp., or Haemophilus influenzae. 1.2 Infections of the Genitourinary Tract Due to Escherichia coli, Proteus mirabilis, or Enterococcus faecalis. 1.3 Infections of the Skin and Skin Structure Due to Streptococcus spp. (α- and β-hemolytic isolates only), Staphylococcus spp., or E. coli. 1.4 Infections of the Lower Respiratory Tract Due to Streptococcus spp. (α- and β-hemolytic isolates only), S. pneumoniae, Staphylococcus spp., or H. influenzae. 1.5 Gonorrhea, Acute Uncomplicated (ano-genital and urethral infections) due to Neisseria gonorrhoeae. Because of high rates of amoxicillin resistance, amoxicillin tablets, USP are not recommended for empiric treatment of gonorrhea. Amoxicillin tablets, USP use should be limited to situations where N. gonorrhoeae isolates are known to be susceptible to amoxicillin. 1.6 Triple Therapy for Helicobacter pylori with Clarithromycin and Lansoprazole Amoxicillin tablets, USP, in combination with clarithromycin plus lansoprazole as triple therapy, are indicated for the treatment Leer el documento completo